Sbi Securities Co., Ltd. Arbutus Biopharma Corp Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 43,294 shares of ABUS stock, worth $147,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,294
Previous 78,894
45.12%
Holding current value
$147,199
Previous $275 Million
51.41%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ABUS
# of Institutions
187Shares Held
113MCall Options Held
874KPut Options Held
708K-
Morgan Stanley New York, NY23.8MShares$80.9 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$45.2 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$39.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$35.5 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$30.9 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $510M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...